RWM
EBS icon

Rialto Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Rialto Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763 Hold
91
– – ﹤0.01% 1473
2026
Q1 		$756 Hold
91
– – ﹤0.01% 1215
2025
Q4 		$1.13K Hold
91
– – ﹤0.01% 954
2025
Q3 		$803 Hold
91
– – ﹤0.01% 1012
2025
Q2 		$581 Buy
+91
New +$521 ﹤0.01% 1068

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Rialto Wealth Management's EBS Position: Q2 2026 in Review

Rialto Wealth Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 91 shares worth $763. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Rialto Wealth Management first reported a position in EBS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.13K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Rialto Wealth Management held 91 shares of Emergent Biosolutions worth $763 as of Q2 2026.
  • Rialto Wealth Management left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1473 holding.
  • Rialto Wealth Management first reported a position in Emergent Biosolutions in Q2 2025 and has held it in 5 quarters since.
  • Rialto Wealth Management's Emergent Biosolutions position peaked at $1.13K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.